Home > Insider Trading > Filing (0000921895-23-002033)

Filing Details

Accession Number:: 0000921895-23-002033
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-18 16:34:57
Reporting Period:: 2023-08-16

Accepted Time:: 2023-08-18 16:34:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1051514	Strata Skin Sciences Inc.	SSKN	Surgical & Medical Instruments & Apparatus (3841)	133986004

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1640809	22Nw Fund, Lp	590 1St Ave. S Unit C1 Seattle WA 98104	No	No	Yes	No
1694297	22Nw, Lp	590 1St Ave. S Unit C1 Seattle WA 98104	No	No	Yes	No
1770436	R. Aron English	590 1St Ave. S Unit C1 Seattle WA 98104	No	No	Yes	No
1770575	22Nw Fund Gp, Llc	590 1St Ave. S Unit C1 Seattle WA 98104	No	No	Yes	No
1783663	22Nw Gp, Inc.	590 1St Ave. S Unit C1 Seattle WA 98104	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-16	1,853,056	$0.55	5,369,954	No	4	P	Indirect	By: 22NW Fund, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By: 22NW Fund, LP

Footnotes

This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron R. English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4799 to $0.5600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.